Management of Acute Pulmonary Embolism. Judith Hurdman Consultant Respiratory Physician

Similar documents
RISK STRATIFICATION OF PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM. David Jiménez, MD, PhD, FCCP Ramón y Cajal Hospital, IRYCIS Madrid, Spain

Massive and Submassive Pulmonary Embolism: 2017 Update and Future Directions

Disclosures. Objectives

Is Thrombolysis Only for a Crisis?

Acute and long-term treatment of PE. Cecilia Becattini University of Perugia

Updates in venous thromboembolism. Cecilia Becattini University of Perugia

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

Pulmonary embolism: Acute management. Cecilia Becattini University of Perugia, Italy

Acute and long-term treatment of VTE. Cecilia Becattini University of Perugia

Case. Case. Management of Pulmonary Embolism in the ICU

PE service. 65 years old lady. What would you do next? Risk stratification. What would you do next? Regional College Lecture PE Management

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital

Epidemiology. Update on Pulmonary Embolism. Keys to PE Management 5/5/2014. Diagnosis. Risk stratification. Treatment

Heart Health ESC Guidelines on the diagnosis and management of acute pulmonary embolism

Venous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year.

The spectrum of clinical outcome of PE

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical

PE Pathway. The charts are listed as follows:

Epidemiology of Pulmonary Embolism (PE)

Acute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144

Management of Intermediate-Risk Pulmonary Embolism

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting

Catheter-directed Thrombolysis for Pulmonary Embolism

Acute Management of Pulmonary Embolism

Chapter 1. Introduction

Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS

Single-Center, Retrospective, Observational Analysis of Patients with Submassive Pulmonary Embolism (PE) Receiving Catheter- Directed Thrombolysis

What is New in Acute Pulmonary Embolism? Interventional Treatment. Prof. Nils Kucher University Hospital Bern Switzerland

Use of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group

Ryan Walsh, MD Department of Emergency Medicine Madigan Army Medical Center

DECLARATION OF CONFLICT OF INTEREST

Management of Massive and Sub-Massive Pulmonary Embolism

Epidemiology: Incidence VTE: Mortality Morbidity Risk Factors: Acute Chronic : Genetic

Mark H. Meissner, MD Peter Gloviczki Professor of Venous & Lymphatic Disorders University of Washington School of Medicine

Risk-Based Evaluation and Management of VTE

RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS.

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Thrombus Removal in Acute Pulmonary Embolism: When and How?

Updates in Management of Pulmonary Embolism (PE) David Ming, MD Duke Hospital Medicine July 24, 2017 Hilton Head, SC

Pulmonary Embolism Pathway

Cover Page. The handle holds various files of this Leiden University dissertation.

PE is a difficult diagnosis that may be missed because of non-specific clinical presentation.

Τί κάνουμε όταν πάσχει η δεξιά κοιλία Οξεία πνευμονική εμβολή. Βασίλειος Σαχπεκίδης Επιμελητής Α Καρδιολογίας Γ.Ν.Θ. Παπαγεωργίου

Guideline for Thrombolysis Therapy in Pulmonary Embolism

RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS.

Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS

A 50-year-old woman with syncope

Management of Pulmonary Embolism. Michael Hooper, M.D., MSc Associate Professor, Pulmonary and Critical Care Medicine Eastern Virginia Medical School

Optimal Management of Intermediate-Risk Pulmonary Embolism

Recent advances in the management of pulmonary embolism. Kodati Rakesh SR Pulmonary medicine

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC

The Evidence Base for Treating Acute DVT

Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model

Diagnosis and Treatment of Pulmonary Embolism: High-Tech versus Low- Tech, which way to go?

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism. Rajat Deo, MD, MTR

Interventional Management of Acute Pulmonary Embolism

Management of sub-massive and massive pulmonary embolism:

Severe pulmonary embolism: Catheter-based thrombolysis and medical treatment

Diagnosis and initial treatment of patients with suspected pulmonary thromboembolism

Catheter Directed Interventions for Pulmonary Embolism

Θεραπεία και Πρόληψη Θρομβώσεων και Πνευμονικών Εμβολών Τι μάθαμε το 2017; Τι περιμένουμε το 2018;

Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE. Mark Goodwin, MD

VTE & Medical Patients: Case Scenario

How and Why to Form a PERT, Pulmonary Embolism Response Team

PULMONARY EMBOLISM -CASE REPORT-

4/18/2018. Objectives. Background. 1) Compare and contrast the various validated tools for the identification of patients with pulmonary embolism

Duration of Anticoagulation? Peter Verhamme MD, PhD Department of Cardiovascular Medicine University of Leuven Belgium

The OPTALYSE PE Trial Reducing thrombolytic dose and treatment times with EKOS in the treatment of pulmonary embolism patients

SESSION 4 12:45 2:15 PM

National Institute for Health and Care Excellence

Suspected Pulmonary embolus Ambulatory Pathway. Document Title. Date Issued/Approved: Date Valid From: 11/11/17. Date Valid To: 11/05/18

National Institute for Health and Care Excellence

Deep Vein Thrombosis and Pulmonary Embolus: Updates From ACCP, AC Forum & ESC

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism

PULMONARY EMBOLISM AND PERT. Jonathon Kirkland, DO OSU Department Chair, Radiology Head of Interventional Radiology

Rationale for catheter directed therapy in pulmonary embolism

DEEP VEIN THROMBOSIS (DVT): TREATMENT

IDEAL MANAGEMENT OF PULMONARY EMBOLISM DISCLOSURES

Venous Thromboembolic Disease Update

Emergency Pulmonary Embolectomy after Failed Thrombolysis in a Community Hospital: A Choice of Institutional Preference?

ORIGINAL INVESTIGATION. Thrombolysis vs Heparin in the Treatment of Pulmonary Embolism

L embolia polmonare ad alto rischio, dalla diagnosi alla terapia riperfusiva.

Pulmonary Embolism Newer Concepts and Role of Thrombolysis

Challenges in the management of acute pulmonary embolism

NUH Emergency Department. Guideline for Diagnosis & Treatment of PE (Massive and Non-Massive) in Adults only

PULMONARY EMBOLISM/VTE CARE PROCESS MODEL

UC SF. Division of General Internal Medicine UNIVERSITY OF CALIFORNIA SAN FRANCISCO, DIVISION OF HOSPITAL MEDICINE

Oxford Medicine Online

The clinical relevance of AMPLIFY programme

A VENOUS THROMBOEMBOLISM (VTE) TOWN HALL: Answering Your Top Questions on Treatment and Secondary Prevention

Anticoagulation Forum: Management of Tiny Clots

Identification of intermediate-risk patients with acute symptomatic pulmonary embolism

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

Screening for CETPH after acute pulmonary embolism: is it needed? Menno V. Huisman Department of Vascular Medicine LUMC Leiden

How long to continue anticoagulation after DVT?

Pulmonary Embolectomy:

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Pulmonary Embolism. current concepts. Dr Nick Taylor Visiting Emergency Specialist Teaching Hospital Karapitiya

Transcription:

Management of Acute Pulmonary Embolism Judith Hurdman Consultant Respiratory Physician Judith.hurdman@sth.nhs.uk

Overview Risk Stratification Who can be managed as an outpatient? To thrombolyse or not to thrombolyse? Follow up & Anticoagulation

Nomenclature of Risk Stratification High Risk Intermediate Risk Low Risk Massive Submassive Low Risk

Stratifying Risk

Risk-adjusted management algorithm Konstantinides et al. Eur Heart J 2014; pii: ehu283

When a PE is diagnosed, what further information is necessary to risk stratify this patient?

Strategies for management of acute PE require an individual assessment clinical status to estimate PE related early mortality risk Clinical features Indicators of cardiorespiratory health Co-morbidities PESI score Biomarkers reflecting RV dysfunction BNP RV dysfunction on echocardiogram Increased RV size on CT scan Biomarkers reflecting myocardial injury Troponin Risk of further events USS of legs Atrial or ventricular thrombi on CT scan or echocardiogram

N=15,531 PE Severity Index

Original and simplified pulmonary embolism severity index (PESI)

Risk of mortality at 30 days by PESI score

Combining ESC and PESI: 2014 ESC guidelines Konstantinides et al. Eur Heart J 2014; pii: ehu283

RV:LV Ratio on transverse CT section good predictive value for adverse outcome in acute PE N=13162 Meta-analysis 49 studies Meinel FG et al Am J Med 2015;128(7):747-59

Measurement of RV / LV ratio Normal RV / LV ratio 1 RV / LV ratio >1-1.5 = moderate RV dilatation RV / LV ratio > 1.5 = severe RV dilatation John G et al. Biomed Res Int. 2014

High lactate predicts adverse outcome in 496 normotensive patients Vanni S et al. Thorax 2015;70:333-338

Case 1 51 year old male with pleuritic chest pain for 2days Sats 95% on air, pulse 90bpm, BP 132/84 No past medical history

Case 1 CTPA confirms PE with RV:LV ratio 0.8 indicating the absence of RV dysfunction

Case 1 management plan Patient has low risk PESI score = 51 age + 10 Male = 61 Simplified PESI = 0 Suitable for ambulatory care with LMWH or DOAC Is any further information required?

Features suggesting inpatient management required Haemodynamic instability Active or high risk bleeding PE while anticoagulated Co-existing major DVT Severe chest pain Renal or liver failure Social factors/difficulty with follow up Zontag et al J of throm & Haemostasis 2011:9(8) 1500-7 Davies et al erj 2007;30(4):708-14

What if his RV:LV ratio was 1.05?

Mild increase in RV:LV ratio in otherwise low risk patient does not preclude ambulatory care In patients who are low-risk on PESI score but mildly elevated RV:LV ratio on CT, check High sensitivity troponin

Outpatient management of low risk PE Outpatient management of low risk patients is safe and associated with good patient satisfaction Clinical risk tools and exclusion criteria identify patients suitable for outpatient management Piran et al Thrombosis Research 2013 32;515-9 Davies, CWH et al ERJ 2007 30(4);708-14 Zontag et al ERJ 2013 42; 134-44

Thrombolysis

Case 2 88 year lady PMH Hypothyroidism, OA Found on floor by pharmacist delivering meds Ambulance called - BP 80/54 in A&E Sats 92% on 35% oxygen Troponin 54

CTPA confirmed extensive PE with RV strain RV / LV ratio 1.7 indicating the presence of RV dysfunction

Key factors contributing to haemodynamic collapse in acute pulmonary embolism Konstantinides et al. Eur Heart J 2014; pii: ehu283

Case 2 BP 80/54 Requires reperfusion therapy Thrombolyse if no contra-indications If contraindications Refer for surgical embolectomy Refer for catheter-based therapy Conservative management

Contraindications to thrombolysis Contraindications to thrombolysis that are considered absolute in MI may become relative in a patient with immediately life threatening PE

Streptokinase & heparin versus heparin alone in high risk pulmonary embolism: a randomized controlled trial 8 high risk PE 4 heparin 4 heparin and streptokinase Heparin group: all died Streptokinase group: all survived Jerjes-Sanchez C et al. J Thromb Thrombolysis 1995;2:227

Thrombolysis in PE: prompt haemodynamic benefits Echocardiography: paradoxical septal motion rtpa + Heparin Heparin alone S Konstantinides, Am J Cardiol 1998;82:966-970

But her BP has recovered, what now? Arrived in A&E BP 80/54 but after IV fluids BP 115/74 Hypotension is defined as systolic BP <90 or drop of 40mmHg for >15minutes, requirement for inotropes or clinical signs of shock Use other features to decide whether to thrombolyse patient currently an intermediate high risk PE.

Should you thrombolyse patients with intermediate high risk PE?

Risk-adjusted management algorithm Konstantinides et al. Eur Heart J 2014; pii: ehu283

RCTs in Intermediate Risk PE Chatterjee et al JAMA 2014;311:2414

PEITHO: primary efficacy outcome n=1006 Tenecteplase 30 50 mg Meyer et al N Engl J Med 2014;370:15

PEITHO: analysis of primary efficacy outcome Meyer et al N Engl J Med 2014;370:15

PEITHO: safety outcomes Meyer et al N Engl J Med 2014;370:15

PEITHO Trial showed no long term benefit in mortality or CTEPH rates

Effect of Age Meyer et al N Engl J Med 2014;370:15

Moderate pulmonary embolism treated with thrombolysis (MOPETT trial) n=121 Alteplase 50mg Sharifi M et al Am J Card 2012

Catheter directed therapy in intermediate high risk patients Lower risk of bleeding than systemic thrombolysis but likely higher than anticoagulation alone More effective at reducing PA pressure, RV strain and clot burden than anticoagulation alone but similar mortality rates Further studies needed regarding long term clinical benefits Consider in deteriorating patient where thrombolysis has failed or is contraindicated Interventional procedures guidance [IPG524]NICE 2015

Suggested to withhold routine thrombolysis in Intermediate High Risk PE Monitor closely - HDU/CCU Consider thrombolysis: Clinical worsening +ve DVT High/rising lactate Clinical impression If young age Need better tools to identify which patients to reperfuse Goldhaber SZ JACC 2017 69(12) 1545-8 Thrombolysis Dose weight adjusted dose consider half dose for >75 years

Follow up & anticoagulation

Sheffield PE Follow up Pathway Anticoagulation specialist nurse review after discharge Screen for malignancy Educate & counsel MDT discussion Review in PE clinic with haematology and respiratory consultant at 3/12 if appropriate Assess recovery and need for further investigation Advise on duration of anticoagulation Condliffe, RA Thromb J 2016 Dec; 14:47

Can we predict who is at high risk of recurrent VTE based on presentation? 570 patients with first episode VTE Split into 4 groups Group A: surgery within 6 weeks (86 patients) Group C: idiopathic (193) Group D: other transient risk factor for VTE (279) Eg cocp, lower limb fracture, concurrent illness Baglin et al, Lancet 2003

Duration of anticoagulation? PE following a surgical intervention 3-6 months PE with a transient risk factor 3-6 months but increased risk of recurrence compared to post surgical Idiopathic 6 months minimum, consider long term Life threatening idiopathic: consider long term anticoagulation Recurrent idiopathic: long term or until risks outweigh benefits If require long term anticoagulation, consider low dose DOAC. Review risk assessment annually Agnelli et al New Engl J Med 2013;368:699 Wells, PS Chest 2016 150(5) 1059-68

A small number of patient who are breathless after a PE have CTEPH Klok FA et al Blood Reviews 2014

A normal Q scan excludes CTEPH Q scanning is an excellent screening test for CTEPH The diagnosis may be missed on CT by nonspecialists 48

In Conclusion Risk assessment involves physiological parameters together with markers of RV dysfunction and RV ischaemia Outpatient management is safe in low risk patients even with mild RV dilatation on CT if troponin is negative The role of thrombolysis and CDT in intermediate high risk PE is unclear Increased age is a significant risk factor for bleeding with thrombolysis A combined respiratory/haematology PE clinic allows optimal assessment of need for further cardiorespiratory/haematological investigation and of optimal duration of anticoagulation Patients with SOB following previous VTE need evaluation for Chronic thromboembolic disease and CTEPH

Guidelines BTS Guideline Outpatient management of PE published soon